Regulation 191 Amendment of regulation 233 (exemption for supply etc under a PGD by a person conducting a retail pharmacy business)I1F1
United Kingdom
For regulation 233(7) substitute—
“(7)Condition F is that when the prescription only medicine is supplied or (as the case may be) administered—
(a)in Northern Ireland, a UKMA(NI), UKMA(UK), EU marketing authorisation, Article 126a authorisation, certificate of registration, THR(NI) or THR(UK), or
(b)in Great Britain, a UKMA(GB), UKMA(UK), certificate of registration, THR(GB) or THR(UK),
is in force in relation to it.”.
Annotations
Textual amendments
- F1
Reg. 191 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 145
Commencement
- I1
Reg. 191 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1